To further confirm the role of adipocyte-SPARC on ovarian tumour growth in vivo, we injected ID8 cells with SP+/+ and SP–/– omental adipocytes (1:2, cancer cell:adipocyte ratio) subcutaneously in 6-week-old female athymic nude mice. Here, SPARC is linked to ovarian neoplasm.